Evotec AG (EVTG.DE)

EVTG.DE on Xetra

3.45EUR
11:35am EDT
Change (% chg)

€0.04 (+1.09%)
Prev Close
€3.41
Open
€3.42
Day's High
€3.47
Day's Low
€3.38
Volume
372,474
Avg. Vol
773,318
52-wk High
€4.19
52-wk Low
€2.42

EVTG.DE

Chart for EVTG.DE

About

Evotec AG (Evotec) is a drug discovery and development company. The Company is engaged in providing drug discovery solutions to the pharmaceutical, biotechnology and academic sectors. The Company has two segments: EVT Execute and EVT Innovate. EVT Execute offers stand-alone or integrated drug discovery solutions for collaborator... (more)

Overall

Beta: 0.63
Market Cap(Mil.): €449.38
Shares Outstanding(Mil.): 131.78
Dividend: --
Yield (%): --

Financials

  EVTG.DE Industry Sector
P/E (TTM): -- 434.54 39.84
EPS (TTM): -0.03 -- --
ROI: -2.12 -5.70 15.61
ROE: -2.53 -5.69 16.64
Search Stocks

BRIEF-Kongsberg Gruppen: Sunnmøre District Court rules in case between RRM and KE

* Sunnmøre District Court ruled in the case between Rolls Royce Marine (RRM) and Kongsberg Evotec in the matter relating to the Norwegian Marketing Act and the related claims for a ban on future sales activities in relation to certain products related to seismic vessels

04 Jun 2015

BRIEF-Evotec to report Q1 results on May 12

* news: evotec to report first quarter 2015 results on 12 may 2015 Source text for Eikon: Further company coverage:

05 May 2015

BRIEF-Evotec agrees collaboration with Asahi Kasei

* Enters multi-target screening collaboration on several ion channel targets, with Asahi Kasei subsidiary

26 Mar 2015

UPDATE 1-Evotec shares surge on Sanofi strategic alliance

* Evotec shares jump to highest since end July (Adds further details of deal, share price, trader comment)

20 Mar 2015

BRIEF-Evotec, Second Genome agree microbiome collaboration

* Second Genome and Evotec to collaborate in microbiome discovery and development

13 Mar 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: ValuEngine, Inc.
$49.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks